You are here

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Phase I/II study of Resiquimod as an immunologic adjuvant for NY-ESO-1 protein vaccination in patients with melanoma

 

Online download statistics by month:

Online download statistics by month: January 2020 to August 2024

AbstractFullPdf
Jan 2020031
Feb 2020031
Apr 2020011
May 2020080
Jun 2020080
Jul 2020040
Aug 2020030
Sep 2020090
Oct 2020020
Nov 2020050
Dec 2020050
Jan 2021020
Feb 2021001
Apr 2021042
May 2021010
Jun 2021050
Jul 2021060
Aug 2021021
Sep 2021020
Oct 2021053
Nov 2021064
Dec 2021051
Jan 2022060
Feb 2022050
Mar 2022042
Apr 2022072
May 20220181
Jun 20220171
Jul 20220101
Aug 2022081
Sep 20220120
Oct 20220120
Nov 20220168
Dec 20220100
Jan 2023040
Feb 20230240
Mar 2023051
Apr 2023011
Jun 2023021
Jul 2023012
Aug 2023032
Sep 2023031
Oct 2023013
Nov 2023053
Dec 2023032
Jan 2024093
Feb 20240111
Mar 2024041
Apr 20240160
May 2024060
Jun 2024080
Jul 20240122
Aug 2024061
Total033855